H. Lundbeck A/S

In News

Lundbeck announces positive Phase 2 long-term data for bexicaserin in rare childhood-onset epilepsies, at American Epilepsy Society (AES) Annual Meeting - TradingView

TradingView - Dec 06, 2025

Novo Nordisk’s Miriam Frieden to lead BD at Lundbeck - biocentury.com

biocentury.com - Dec 02, 2025

H. Lundbeck Launches Bid for Avadel in Move to Scuttle Alkermes Deal - The Wall Street Journal

The Wall Street Journal - Nov 14, 2025

Alkermes responds to potential rival bid for Avadel from Lundbeck - Investing.com

Investing.com - Nov 14, 2025

Lundbeck inks licence option deal with Contera Pharma - European Biotechnology Magazine

European Biotechnology Magazine - Oct 20, 2025

Avadel Gets Acquisition Proposal From Lundbeck Weeks After Inking Agreement With Alkermes - MSN

MSN - Nov 16, 2025

Lundbeck and Contera Pharma partner in neurological disorders - BioWorld MedTech

BioWorld MedTech - Oct 21, 2025

H Lundbeck A/S : ANNOUNCEMENT FOR THE PURPOSES OF ARTICLE 17 "MAR" RULES (EU) NO. 596/2014 (INSIDE INFORMATION) AND RULE 2.8 OF THE IRISH TAKEOVER PANEL ACT 1997, TAKEOVER RULES, 2022 (THE “IRISH TAKEOVER RULE - marketscreener.com

marketscreener.com - Nov 26, 2025

Lundbeck's Higher Buyout Proposal Challenges Alkermes' Pending $2 Billion Avadel Deal - Benzinga

Benzinga - Nov 14, 2025

Denmark Pharmaceutical Market Forecast and Company Analysis - GlobeNewswire

GlobeNewswire - Aug 05, 2025

Avadel deems Lundbeck offer ‘superior’ to Alkermes’: Deals Report - biocentury.com

biocentury.com - Nov 18, 2025

Lundbeck files for marketing authorization across key Asian markets for Vyepti® (eptinezumab) for the preventive treatment of migraine - TradingView

TradingView - Nov 13, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment